Effects of lipopolysaccharide and chelator on mercury content in the cerebrum of thimerosal-administered mice

Environmental Toxicology and Pharmacology

Volumn 24, Issue 3, 2007, Pages 316-320

  Minami, Takeshi ^a   Oda, Keisuke ^a   Gima, Naoya ^a   Yamazaki, Hideo ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Cerebrum; d Penicillamine; Dimercaprol; Lipopolysaccharide; Mercury; Thimerosal

Indexed keywords

CHELATING AGENT; DIMERCAPROL; HEAVY METAL; LIPOPOLYSACCHARIDE; MERCURY; PENICILLAMINE; THIOMERSAL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

MUS;

EID: 34648819668     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2007.08.004     Document Type: Article

References (24)

1. Bernard S., Enayati A., Roger H., Binstock T., and Redwood L. The role of mercury in the pathogenesis of autism. Mol. Psychiatry 7 (2002) S42-S43
2. Bigham M., and Copes R. Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease. Drug Safe.: Int. J. Med. Toxicol. Drug Exp. 28 (2005) 89-101
3. Burbacher T.M., Shen D.D., Liberato N., Grant K.S., Cernichiari E., and Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ. Health Perspect. 113 (2005) 1015-1021
4. Clarkson T.W. The three modern faces of mercury. Environ. Health Perspect. 110 (2002) 11-23
5. Clements C.J., and McIntyre P.B. When science is not enough-a risk/benefit profile of thimerosal-containing vaccines. Expert Opin. Drug Safe. 5 (2006) 17-29
6. François g., Duclos P., Margolis H., Lavanchy D., Siegrist C.-A., Meheus A., Lambert P.-H., Emiroǧlu N., MPharm S.B., and Van Damme P. Vaccine safety controversies and the future of vaccination programs. Pediatr. Infect. Dis. J. 24 (2005) 953-961
7. Harry G.J., Harris M.W., and Burka L.T. Mercury concentrations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol. Lett. 154 (2004) 183-189
8. Havarinasab S., and Hultman P. Alteration of the spontaneous systemic autoimmune disease in (NZB × NZW)F1 mice by treatment with thimerosal (ethyl mercury). Toxicol. Appl. Pharmacol. 214 (2006) 43-54
9. Madsen K.M., Lauritsen M.B., Pedersen C.B., Thorsen P., Plesner A.-M., Andersen P.H., and Mortensen P.B. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 112 (2003) 604-606
10. Mastsuo N., Suzuki T., and Akagi H. Mercury concentration in organs of contemporary Japanese. Arch. Environ. Health 44 (1989) 298-303
11. Minami T., Okazaki J., Kawabata A., Kawaki H., and Okazaki Y. Lipopolysaccharide-induced platinum accumulation in the cerebral cortex after cisplatin administration in mice: involvement of free radicals. Environ. Toxicol. Pharmacol. 2 (1996) 321-326
12. Minami T., Okazaki J., Kawabata A., Kuroda R., and Okazaki Y. Penetration of cisplatin into mouse brain by lipopolysaccharide. Toxicology 130 (1998) 107-113
13. Minami T., Okazaki J., Kawabata A., Kawaki H., Okazaki Y., and Tohno Y. Roles of nitric oxide and prostaglandins in the increased permeability of the blood-brain barrier caused by lipopolysaccharide. Environ. Toxicol. Pharmacol. 5 (1998) 35-41
14. Minami T., Sakita Y., Ichida S., and Dohi Y. Gender difference regarding selenium penetration into the mouse brain. Biol. Trace Element Res. 89 (2002) 85-93
15. Mutter J., Naumann J., Schneider R., Walach H., and Haley B. Mercury and autism: Accelerating evidence?. Neuroendocrinol. Lett. 26 (2005) 439-446
16. Orlikowsky T.W., Trüg C., Neunhoeffer F., Deperschmidt M., Eichner M., and Poets C.F. Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection. J. Perinatol. 26 (2006) 115-119
17. Pichichero M.E., Cernichiari E., Loprelato J., and Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360 (2002) 1737-1741
18. Singh A.K., and Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 201 (2004) 197-207
19. Slodownik D., and Ingber A. Thimerosal-is it really irrelevant?. Contact Dermat. 53 (2005) 324-326
20. Speziali M., and Sabbioni E. Minor and trace element contents in pituitary gland of "normal" humans: an evaluation of analytical data. Microchem. J. 79 (2005) 383-391
21. Stajich G.V., Lopez G.P., Harry S.W., and Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J. Pediatr. 136 (2000) 679-681
22. 2+ concentration of rat cerebellar neurons. Toxicology 195 (2004) 77-84
23. Yel L., Brown L.E., Su K., Gollapudi S., and Gupta S. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int. J. Mol. Med. 16 (2005) 971-977
24. Zarini S., Gijon M.A., Folco G., and Murphy R.C. Effect of arachidonic acid reacylation on leukotriene biosynthesis in human neutrophils stimulated with GM-CSF and fMLP. J. Biol. Chem. 281 (2006) 10134-10142